Viewing StudyNCT00330681



Ignite Creation Date: 2024-05-05 @ 4:54 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00330681
Status: COMPLETED
Last Update Posted: 2017-05-17
First Post: 2006-05-26

Brief Title: Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis ALS
Sponsor: Mitsubishi Tanabe Pharma Corporation
Organization: Mitsubishi Tanabe Pharma Corporation

Conditions & Keywords Data

Conditions:
Name
Amyotrophic Lateral Sclerosis ALS
Keywords:
Name View
free radical scavenger View
Amyotrophic lateral sclerosis View